Braveheart Bio Targets $1.2 Billion Valuation in IPO
The heart-disease drug developer is seeking up to $318.8 million for clinical trials and research.
Archive
Search
SpaceX Completes Record $75 Billion Public Offering
The rocket and satellite company entered Nasdaq trading at a valuation above $1.7 trillion.
Cerebras Shares Soar in $5.55 Billion Nasdaq Debut
The AI chipmaker nearly doubled its offering price as investors sought another route into compute infrastructure.
